Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.62% | 29.12% | 19.75% | 29.68% | 120.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.62% | 29.12% | 19.75% | 29.68% | 120.89% |
| Cost of Revenue | 1.95% | 8.60% | 11.84% | -3.72% | 6.56% |
| Gross Profit | 127.64% | 96.10% | 62.23% | 38,257.78% | 160.94% |
| SG&A Expenses | 50.80% | 5.81% | -4.05% | 271.40% | 14.80% |
| Depreciation & Amortization | 4.77% | 8.72% | 4.82% | 43.12% | 9.60% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.20% | 8.14% | 8.99% | 10.23% | 7.74% |
| Operating Income | 1,396.99% | 3,402.10% | 134.29% | 170.54% | 97.45% |
| Income Before Tax | 46.97% | 176.82% | 98.05% | -246.87% | 98.87% |
| Income Tax Expenses | 1,439.32% | 209.60% | 142.79% | -266.11% | 95.99% |
| Earnings from Continuing Operations | -58.38% | 170.56% | 92.16% | -159.99% | 98.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -59.38% | -528.54% | -89.95% | 4.57% | -109.50% |
| Net Income | -58.56% | 89.54% | 92.93% | -114.33% | 98.66% |
| EBIT | 1,396.99% | 3,402.10% | 134.29% | 170.54% | 97.45% |
| EBITDA | 994.45% | 1,015.39% | 225.45% | 227.84% | 104.23% |
| EPS Basic | -37.84% | 90.78% | 93.67% | -150.00% | 98.69% |
| Normalized Basic EPS | 35.96% | 219.27% | 102.49% | 48.97% | 61.01% |
| EPS Diluted | -37.84% | 90.78% | 91.67% | -141.47% | 98.69% |
| Normalized Diluted EPS | 35.96% | 219.27% | 102.49% | 48.97% | 61.01% |
| Average Basic Shares Outstanding | 15.03% | 13.54% | 11.75% | -14.27% | 2.38% |
| Average Diluted Shares Outstanding | 15.03% | 13.54% | 11.75% | -14.27% | 2.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -3.43% | -- | -- |
